Cymab ApS — Credit Rating and Financial Key Figures

Cymab ApS (CVR number: 39859173) is a company from KØBENHAVN. The company recorded a gross profit of -1951.7 kDKK in 2024. The operating profit was -5501.7 kDKK, while net earnings were -4627.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -28.3 %, which can be considered poor and Return on Equity (ROE) was -50.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -50.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Cymab ApS's liquidity measured by quick ratio was 6.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.